Innopharmax (ROCO:4172) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4172 Innopharmax Inc ROCO:4172
49 GF Score
Price NT$13.30
GF Value NT$30.33
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Innopharmax Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Innopharmax's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ROCO:4172 vs ZTS, UTHR: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Innopharmax's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innopharmax Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innopharmax's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Innopharmax's Margin of Safety % (DCF FCF Based) falls into.


ROCO:4172
49GF Score
Innopharmax Inc ROCO:4172
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innopharmax (ROCO:4172) Overvalued in 2026?

Based on GuruFocus' analysis, Innopharmax stock appears to be undervalued. The current stock price of NT$13.30 is trading 56.1% below its estimated GF Value™ of NT$30.33. GuruFocus considers Innopharmax to be Possible Value Trap.

Key valuation signals for ROCO:4172:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: NT$30.33 vs. price of NT$13.30 (56.1% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Innopharmax Business Description

Address No. 22, Lane 478, Ruiguang Road, 9th Floor, Neihu District, Taipei, TWN, 11492
Innopharmax Inc is a Taiwan based specialty pharmaceutical company. It is focused on the development and commercialization of products for the treatment of oncology and specialty. The company's products include anti-infection agents, contrast agents, oncology agents, immunological agents, drugs for rare diseases and others.
49GF Score

Get the complete analysis for ROCO:4172

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.30
Price
NT$30.33
GF Value